We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Tyler Technologies
TYL
$12.8B
| $308K | 0.03% |
1,509
+173
| +13% | +$34.3K |
|
|
EPZM
977
DELISTED
Epizyme, Inc
EPZM
| $307K | 0.03% |
24,742
-18,024
| -42% | -$202K |
|
|
FTSI
978
DELISTED
FTS International, Inc. Common Stock
FTSI
| $307K | 0.03% |
1,535
-2,885
| -65% | -$516K |
|
979
Brunswick
BC
$5.28B
| $306K | 0.03% |
+6,087
| New | +$307K |
|
980
Quad
QUAD
$525M
| $305K | 0.03% |
25,670
-43,486
| -63% | -$583K |
|
981
TD Synnex
SNX
$20.2B
| $305K | 0.03% |
+6,390
| New | +$302K |
|
|
TTSH
982
DELISTED
Tile Shop Holdings
TTSH
| $305K | 0.03% |
53,815
-92,385
| -63% | -$600K |
|
983
Cogent Communications
CCOI
$497M
| $304K | 0.03% |
5,600
-393
| -7% | -$19.4K |
|
984
DXP Enterprises
DXPE
$2.98B
| $304K | 0.03% |
7,806
-13,461
| -63% | -$468K |
|
985
Federal Realty Investment Trust
FRT
$10.3B
| $304K | 0.03% |
2,207
-25
| -1% | -$3.27K |
|
986
Installed Building Products
IBP
$6.57B
| $304K | 0.03% |
+6,272
| New | +$269K |
|
987
Republic Services
RSG
$66B
| $304K | 0.03% |
+3,780
| New | +$291K |
|
|
DOC
988
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $303K | 0.03% |
16,096
-38,236
| -70% | -$681K |
|
989
Kinsale Capital Group
KNSL
$8.51B
| $302K | 0.03% |
4,400
| – | – |
|
990
Spire
SR
$4.85B
| $302K | 0.03% |
+3,669
| New | +$286K |
|
991
Cboe Global Markets
CBOE
$29.9B
| $301K | 0.03% |
+3,155
| New | +$299K |
|
992
Caterpillar
CAT
$387B
| $300K | 0.03% |
+2,217
| New | +$294K |
|
993
Vishay Intertechnology
VSH
$5.43B
| $300K | 0.03% |
16,268
+5,407
| +50% | +$108K |
|
|
SGEN
994
DELISTED
Seagen Inc. Common Stock
SGEN
| $300K | 0.03% |
4,100
-2,046
| -33% | -$146K |
|
|
GMS
995
DELISTED
GMS Inc
GMS
| $299K | 0.03% |
19,774
-23,255
| -54% | -$420K |
|
996
ArcelorMittal
MT
$55.3B
| $299K | 0.03% |
+14,680
| New | +$325K |
|
997
Devon Energy
DVN
$47.3B
| $298K | 0.03% |
9,442
-9,635
| -51% | -$269K |
|
998
Xencor
XNCR
$1.55B
| $298K | 0.03% |
9,584
+214
| +2% | +$7.12K |
|
|
ZEUS
999
DELISTED
Olympic Steel
ZEUS
| $298K | 0.03% |
18,781
+5,481
| +41% | +$98.5K |
|
|
ADAP
1000
DELISTED
Adaptimmune Therapeutics
ADAP
| $297K | 0.03% |
+69,109
| New | +$322K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.